Docetaxel-Based Chemo Promising in Stomach and Esophageal Cancer Docetaxel-Based Chemo Promising in Stomach and Esophageal Cancer

Perioperative treatment with docetaxel-based triplet chemotherapy may beat anthracycline-based triplet chemotherapy in resectable gastric or gastro-esophageal junction adenocarcinoma, according to a randomized clinical trial.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news